Insider Purchases: Inside the Buy
Tag: stock analysis
👟 DICK’S Sporting Goods (DKS): Insiders Buy $2.9M After a 30% Crash
DICK’S Sporting Goods plunged roughly 30% as Foot Locker weakness rattled Wall Street. Then three directors bought $2.94 million. With core DICK’S comps up 4.9%, operating cash flow at $792 million and the stock at 9.3x forward earnings, is Wall Street pricing temporary integration pain like permanent deterioration?
🛢️ NGL Energy Partners (NGL): A $5.1M Insider Buy, a Permian Water Boom — and One Big Debt Question 💧⚡
NGL Energy Partners director John Raymond just put $5.1 million behind the turnaround. With record Permian water volumes, rising EBITDA and heavy institutional ownership, NGL looks increasingly compelling—but leverage keeps our FunStock Index at 7.95/10.
✈️ Alaska Air (NYSE: ALK): Why a 94x P/E May Be Hiding One of Wall Street's Most Interesting Turnarounds
A 94x P/E usually screams "expensive." Alaska Air may be the exception. With a 0.31x Price-to-Sales ratio, a $1 million CEO purchase, 95% institutional ownership, and major Hawaiian Airlines synergies ahead, the market could be misreading today's earnings power.
Medifast (MED) Stock Analysis: Can a Company Trading Below Its Cash Reinvent Itself?
Medifast (NYSE: MED) has nearly $170 million in cash, no debt, insider buying and a bold strategic pivot through Trilivy. But shrinking revenues and GLP-1 competition still cast a long shadow. Here's the complete bull vs. bear case.
🚰 Primo Brands (PRMB): CEO Buys $2M Dip as an $800M Free Cash Flow Giant Emerges 💧⚡
Primo Brands isn't simply selling bottled water.
It's quietly building one of North America's largest hydration infrastructure platforms.
With repeat CEO insider buying, nearly $800 million in annual free cash flow, raised guidance, and exceptional institutional ownership, PRMB deserves a closer look.
⚡ Intel (NASDAQ: INTC): The skAI Is the Limit… But Is the Stock?
Intel finally looks like a company moving in the right direction. AI demand is accelerating, the balance sheet is stronger, Intel Foundry could reshape the company's future, and CEO Lip-Bu Tan is buying shares alongside investors. The turnaround appears increasingly credible. The valuation? That's where patience may still pay.
🗑️ Bill Gates's $108 Million Trash Flex: Why Republic Services (RSG) May Still Be One of the Market's Cleanest Compounders
Garbage rarely excites investors. Bill Gates keeps buying it anyway. Republic Services combines recurring revenue, remarkable pricing power, an irreplaceable landfill network, and disciplined capital allocation—making it one of the market's most dependable compounders, even if its premium valuation warrants patience.
⚡ Ameresco (AMRC): The AI Power Boom, a $1.17M Insider Buy, and a $6.73B Backlog
Artificial intelligence doesn't just require better chips—it requires vastly more electricity. Ameresco sits at the intersection of AI infrastructure, energy modernization, and microgrids, backed by a record $6.73 billion backlog, significant insider buying, and improving operational momentum. The opportunity is compelling, but so are the risks.
🚜 Tractor Supply (TSCO): Why CEO Hal Lawton Just Bought $501,000 of Stock After a 46% Selloff
After falling roughly 46% from its all-time high, Tractor Supply has become one of retail's more intriguing turnaround candidates. CEO Hal Lawton recently invested more than $500,000 of his own money while institutions continue to own over 95% of the company. We examine whether today's valuation reset represents genuine opportunity—or simply reflects slowing fundamentals that still need to improve.
🫀 Boston Scientific (BSX): The CEO Just Bought $9 Million. Is Wall Street Missing Something?
Boston Scientific's stock has been cut nearly in half from its peak, yet the business remains fundamentally strong. With CEO Mike Mahoney buying $9 million worth of shares, a remarkably low 0.71 PEG ratio, billions in annual free cash flow, and overwhelming institutional ownership, is Wall Street overlooking one of healthcare's most attractive GARP opportunities?